Partner Content Partner Content PharmStars Announces “Innovations in Real-World Evidence” Th... PharmStars’ Theme: Innovations in Real-World Evidence
R&D The post-Covid New Normal: a golden opportunity for the NHS? I recently had the pleasure of attending the PING Conference 2022, which had the tagline of ‘
Digital Accelerator aims to promote digital health innovation in Ita... A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise.
Events Partner Content PING Conference 2022 – The Golden Age for Life Sciences Inno... The Golden Age for Life Sciences Innovation
R&D Innovation across the healthcare system is needed to realise... Janssen’s Catherine Taylor, vice-president, EMEA medical affairs, therapy area strategy, discusses the importance of systemic innovation across the healthcare system to realise the full val
Views & Analysis Innovation and access: Improving Europe’s pharmaceutical reg... EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
